Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: a retrospective single center study
出版年份 2022 全文链接
标题
Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: a retrospective single center study
作者
关键词
Type 2 diabetes mellitus, Metformin, Bone, Bone mineral density, Osteoporosis
出版物
DIABETES & METABOLISM
Volume -, Issue -, Pages 101350
出版商
Elsevier BV
发表日期
2022-04-20
DOI
10.1016/j.diabet.2022.101350
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial
- (2021) A. K. Nordklint et al. OSTEOPOROSIS INTERNATIONAL
- Metformin: Is It the Well Wisher of Bone Beyond Glycemic Control in Diabetes Mellitus?
- (2021) Abdul Rahaman Shaik et al. CALCIFIED TISSUE INTERNATIONAL
- Long-term effects of lifestyle and metformin interventions in DPP on bone density
- (2021) A. V. Schwartz et al. OSTEOPOROSIS INTERNATIONAL
- Differential risk of fracture attributable to type 2 diabetes mellitus according to skeletal site
- (2021) John T. Schousboe et al. BONE
- Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
- (2021) Kathrin Kahnert et al. International Journal of Chronic Obstructive Pulmonary Disease
- Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study
- (2020) Juan E. Blümel et al. GYNECOLOGICAL ENDOCRINOLOGY
- The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update
- (2020) Tatiane Vilaca et al. BONE
- Diabetes and Bone Fragility: SGLT2 Inhibitor Use in the Context of Renal and Cardiovascular Benefits
- (2020) Kristen Jackson et al. Current Osteoporosis Reports
- Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus
- (2020) Chin-Hsiao Tseng EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial
- (2019) Silvina Gallo et al. DIABETES OBESITY & METABOLISM
- Adverse effects of SGLT2 inhibitors on bone health
- (2018) Jenny E. Blau et al. Nature Reviews Nephrology
- Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients
- (2018) Inbal Goldshtein et al. Archives of Osteoporosis
- Metformin; an old antidiabetic drug with new potentials in bone disorders
- (2018) Saman Bahrambeigi et al. BIOMEDICINE & PHARMACOTHERAPY
- Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway
- (2018) Lifeng Zheng et al. LIFE SCIENCES
- Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management
- (2017) Stavroula Α Paschou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
- (2017) Suet Ching Chen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
- (2016) Zhong’e Zhou et al. Journal of Diabetes Research
- The Impact of Diabetes and Diabetes Medications on Bone Health
- (2015) Matthew P. Gilbert et al. ENDOCRINE REVIEWS
- Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats
- (2011) Qi-Guang Mai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2
- (2010) Won Gu Jang et al. BONE
- Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats
- (2010) Ying Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesis
- (2010) Masanobu Kawai et al. Nature Reviews Endocrinology
- The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study
- (2009) F.-Y. Hsiao et al. DIABETOLOGIA
- Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
- (2009) M Silvina Molinuevo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started